# A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites

> **NCT04835480** · PHASE2 · RECRUITING · sponsor: **Healthgen Biotechnology Corp.** · enrollment: 220 (estimated)

## Conditions studied

- Cirrhotic Ascites

## Interventions

- **DRUG:** OrsHSA
- **DRUG:** HSA

## Key facts

- **NCT ID:** NCT04835480
- **Lead sponsor:** Healthgen Biotechnology Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-22
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04835480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04835480, "A Phase II Study of OsrHSA in Patients With Decompensated Cirrhotic Ascites". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04835480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*